GRIGIONI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 9.378
EU - Europa 6.713
AS - Asia 6.575
AF - Africa 394
SA - Sud America 371
Continente sconosciuto - Info sul continente non disponibili 345
OC - Oceania 13
Totale 23.789
Nazione #
US - Stati Uniti d'America 9.216
VN - Vietnam 2.118
IT - Italia 1.935
SG - Singapore 1.710
CN - Cina 1.531
GB - Regno Unito 1.428
DE - Germania 780
SE - Svezia 702
HK - Hong Kong 396
FR - Francia 386
UA - Ucraina 365
RU - Federazione Russa 301
IN - India 299
BR - Brasile 253
IE - Irlanda 214
NL - Olanda 159
ZA - Sudafrica 126
JP - Giappone 117
EE - Estonia 113
CA - Canada 97
FI - Finlandia 91
TG - Togo 88
CI - Costa d'Avorio 62
BG - Bulgaria 61
JO - Giordania 60
PH - Filippine 57
AR - Argentina 48
NG - Nigeria 47
BD - Bangladesh 44
KR - Corea 43
SC - Seychelles 36
CH - Svizzera 35
BE - Belgio 32
TH - Thailandia 26
AT - Austria 24
IR - Iran 24
PL - Polonia 22
ID - Indonesia 20
MX - Messico 19
CO - Colombia 18
TW - Taiwan 18
PK - Pakistan 17
ES - Italia 15
IQ - Iraq 15
TR - Turchia 15
EC - Ecuador 14
AU - Australia 12
CL - Cile 12
GR - Grecia 12
LB - Libano 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 11
MA - Marocco 9
JM - Giamaica 8
KE - Kenya 8
CR - Costa Rica 7
EU - Europa 7
PY - Paraguay 7
RO - Romania 7
VE - Venezuela 7
LT - Lituania 6
UY - Uruguay 6
NI - Nicaragua 5
PE - Perù 5
SV - El Salvador 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
HN - Honduras 3
OM - Oman 3
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HT - Haiti 2
HU - Ungheria 2
IL - Israele 2
LY - Libia 2
MY - Malesia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
BF - Burkina Faso 1
BM - Bermuda 1
CY - Cipro 1
FJ - Figi 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
Totale 23.440
Città #
Southend 1.242
Singapore 1.184
Ashburn 963
Fairfield 839
San Jose 659
Chandler 483
Woodbridge 472
Ho Chi Minh City 445
Wilmington 438
Houston 416
Seattle 406
Hanoi 400
Hong Kong 380
Santa Clara 330
Princeton 305
Cambridge 297
Dong Ket 292
Ann Arbor 264
Jacksonville 227
Beijing 221
Council Bluffs 220
Dublin 213
Boardman 187
Milan 183
Padova 151
Nanjing 150
Bologna 140
New York 135
Lauterbourg 134
Westminster 133
Rome 123
Los Angeles 112
Tokyo 106
Berlin 98
Lomé 88
Helsinki 82
Dallas 80
Buffalo 79
Bremen 77
Jinan 74
Shenyang 73
Hefei 68
Haiphong 65
Turin 64
Abidjan 62
Saint Petersburg 62
Amman 60
Sofia 60
Da Nang 56
Changsha 53
San Diego 47
Abeokuta 45
Medford 45
Munich 45
Chicago 44
Frankfurt am Main 43
Zhengzhou 43
Florence 42
Guangzhou 42
Hebei 40
Mülheim 40
Nanchang 40
Naples 39
São Paulo 39
Tianjin 36
Redondo Beach 35
Dearborn 33
Shanghai 33
Verona 31
Jiaxing 30
Brussels 29
Bari 28
London 25
Mahé 23
Toronto 23
Bern 22
Biên Hòa 22
Falkenstein 22
Phoenix 22
Washington 22
Hangzhou 21
Quận Bình Thạnh 21
Redwood City 21
Hải Dương 20
Ningbo 20
Des Moines 18
Falls Church 18
Thái Nguyên 18
Can Tho 17
Montreal 17
Olalla 17
Seoul 17
Yubileyny 17
Atlanta 16
Bắc Ninh 16
Johannesburg 16
Taizhou 16
Las Vegas 15
San Francisco 15
The Dalles 15
Totale 14.832
Nome #
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 1.405
Sicurezza dell'utilizzo delle statine nel paziente trapiantato di cuore:16 anni di esperienza clinica. 327
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 326
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 319
First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation 284
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 260
Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: A meta-analysis 258
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 253
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 247
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 242
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 237
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 222
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 221
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 218
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 216
Cardiac transplantation from a carbon monoxide intoxicated donor. 212
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 211
Electrocardiographic remodeling during cardiac resynchronization therapy 210
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 206
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 205
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 204
Age and heart transplantation: results from a heart failure management unit. 204
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 203
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 202
Post-operative pleural effusion in a heart transplant recipient: A singlecase study of physiotherapy treatment 198
Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. 197
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 195
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 195
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 195
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 194
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 193
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 193
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 193
Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. 192
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 189
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 188
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 188
Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes 187
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 187
Implantation of cardioverter-defibrillator: Effects on shoulder function. 186
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 185
Role of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation in Early Graft Failure After Cardiac Transplantation 181
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 181
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 180
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 176
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 176
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 175
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 175
Efficacia del trattamento a lungo termine con statine nel paziente trapiantato di cuore. 174
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 173
Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets 172
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 172
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 170
Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study 170
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 169
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 169
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 169
Role of severe functional mitral regurgitation in predicting electrical remodeling in idiopathic dilated cardiomyopathy. 168
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 167
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 167
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 165
EURObservational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) 164
Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era 164
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 164
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 163
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 161
Left Atrial Size is a Potent Predictor of Mortality in Mitral Regurgitation Due to Flail Leaflets: Results from a Large International Multicenter Study. 160
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 158
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 158
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 157
Management of asymptomatic mitral regurgitation. 157
RotaFlow and CentriMag Extracorporeal Membrane Oxygenation Support Systems as Treatment Strategies for Refractory Cardiogenic Shock 157
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 157
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 154
Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: A multicenter analysis 154
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 153
Comparative effectiveness of disease-modifying-drugs in elderly patients after incident hospitalization for heart failure 153
The risk of right ventricular failure with current continuous-flow left ventricular assist devices 153
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 152
Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. 151
Outcomes in mitral regurgitation due to flail leaflets a multicenter European study. 151
Heart transplantation in hypertrophic cardiomyopathy. 151
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 151
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 150
Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study 150
Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A Multicenter Long-term International Study 150
Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it? 150
Atrial fibrillation, vascular phenotype, APOE genotype and Alzheimer's Disease: a perspective cohort study 150
Cardiac resynchronization by pacing: an electrical treatment of heart failure 150
Prevalence of substance-related disorders in heart transplantation candidates 148
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 147
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 147
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 147
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 145
Evaluation of postural disorders in patients pre and post heart transplant. 145
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 144
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 144
La misurazione del supporto psico-sociale in cardiologia con l’Interpersonal Support Evaluation List. 144
Quantitation of mitral regurgitation 142
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 142
Totale 19.534
Categoria #
all - tutte 61.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.034 0 0 0 316 225 139 59 158 110 191 430 406
2022/20232.649 259 362 157 341 205 208 78 136 458 101 212 132
2023/2024819 65 122 42 96 58 167 38 34 31 67 55 44
2024/20252.790 153 435 235 220 506 137 156 106 49 201 69 523
2025/20266.326 827 444 497 365 724 354 563 405 1.305 458 203 181
2026/20271.225 92 179 530 424 0 0 0 0 0 0 0 0
Totale 23.789